Tamarack Advisers’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-125,000
Closed -$2.03M 42
2022
Q1
$2.03M Buy
+125,000
New +$2.03M 0.96% 30